MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The Vall d’Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal and observational study enrolling de novo Parkinson’s disease (PD) patients and carriers of PD-linked mutations for biomarker and pathophysiology studies

    D. Samaniego-Toro, L. Domingo-Rodriguez, M. Camprodon-Gómez, M. Armengol-Bellapart, V. González, S. Lucas-Del-Pozo, E. Xicoy, J. Riera-Heredia, D. Montpeyó, M. Martinez-Vicente, A. Laguna, J. Hernandez-Vara (Barcelona, Spain)

    Objective: To describe the study protocol of the Vall d’Hebron Initiative for Parkinson (VHIP) cohort, a prospective, longitudinal and observational cohort study aimed at deeply…
  • 2022 International Congress

    Beyond the subthalamic nucleus: tractography patterns of Magnetic Resonance-guided Focused Ultrasound subthalamotomy

    R. Rodriguez-Rojas, JU. Mañez-Miro, JA. Pineda-Pardo, R. Martinez-Fernandez, M. Del Alamo, JA. Obeso (Madrid, Spain)

    Objective: To identify subthalamic clusters that predict maximum improvement in bradykinesia, rigidity and tremor. To map-out the cortical fingerprint, which predict maximum efficacy. Background: Subthalamotomy…
  • 2022 International Congress

    A novel alpha-synuclein gene (SNCA) missense variant in an Austrian familiy with atypical neuropathological features

    C. Brücke, M. Zech, T. Outeiro, E. Gelpi, A. Zimprich (VIenna, Austria)

    Objective: To offer clinical, genetic and neuropathological information in a novel alpha-synuclein gene (SNCA) missense variant to further our understanding of synucleinopathies. Background: Around 5–10% of…
  • 2022 International Congress

    Validation of a wireless Home-Based Sleep Laboratory for assessment of sleep-related disorders in Parkinson’s disease

    S. Oz, A. Dagay, S. Katzav, D. Wasserman, E. Harduff, Y. Hanein, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the validity of a new wireless wearable system which measures EEG, EOG and sEMG for the assessment of sleep and sleep related…
  • 2022 International Congress

    Does needle size matter in botulinum toxin injection? A crossover randomised controlled trial of microneedle in patients with hemifacial spasm

    S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (bangkok, Thailand)

    Objective: The aim of this study was to compare the severity of  pain and bruises between a microneedle (34-G) and standard needle (30-G) in patients…
  • 2022 International Congress

    What research participants want to know: Feedback from participants in an observational study of Parkinson’s disease

    S. Lettenberger, S. Jensen-Roberts, E. Wagner, M. Pawlik, J. Soto, E. Hartman, P. Yang, E. Nnadika, C. Tarolli, R. Schneider, J. Adams, E. Dorsey, T. Myers (Rochester, USA)

    Objective: To compare participant feedback regarding clinical assessments, patient-reported outcomes (PROs), and digital technologies provided in individual research reports in an observational study of Parkinson’s…
  • 2022 International Congress

    Anatomical Substrates for Motor Subcomponents of Bradykinesia in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Simulation

    MJ. Kim, Y. Shi, Y. Salimpour, WS. Anderson, K. Mills (Baltimore, USA)

    Objective: To evaluate distinct anatomical substrates modulating motor subcomponents of bradykinesia following Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD). Background: PD…
  • 2022 International Congress

    Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation

    A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury (Caçapava, Brazil)

    Objective: Dystonia is a hyperkinetic movement disorder with a complex pathophysiology. The medical treatment includes pharmacological treatment, including botulinum toxin (BoNT), which is considered the…
  • 2022 International Congress

    Evaluation of the association between total electrical energy delivered (TEED) and cognitive function six months after DBS in patients with Parkinson’s disease

    F. Ruggiero, F. Mameli, M. Dini, S. Marceglia, M. Prenassi, L. Borellini, F. Cogiamanian, E. Pirola, E. Zirone, D. Mellace, B. Capetti, L. Remore, G. Fiore, MR. Reitano, N. Maiorana, M. Locatelli, S. Barbieri, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: We aimed to investigate the neuropsychological outcome six months after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkison's disease (PD) patients and…
  • 2022 International Congress

    Investigating inflammatory mechanisms in iPSC-derived LRRK2 microglia

    K. Badanjak, P. Mulica, P. Seibler, M. Ali, C. Venegas, S. Pereira, C. Klein, P. Antony, E. Glaab, A. Grünewald (Esch-Sur-Alzette, Luxembourg)

    Objective: To characterize microglial function and inflammatory mechanisms in LRRK2-associated Parkinson’s disease (PD). Background: PD is a neurodegenerative disease affecting primarily dopaminergic neurons of the…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley